On December 10, 2024, the Chemours Company (Chemours) (NYSE: CC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO₂) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028.

“Today, Chemours Titanium Technologies takes an important step in its continued operational excellence transformation, under Pathway to Thrive, partnering with the PCC Group to gain increased supply reliability through on-site chlorine at our DeLisle TiO₂ facility,” said Denise Dignam, President and CEO of Chemours. “This new partnership, requiring no up-front financial commitment from Chemours, will enable us to lower our manufacturing costs and better serve our customers as their trusted TiO₂ partner of choice. It also reinforces our commitment to the Mississippi Gulf Coast community we have called home for nearly 45 years.”

“Our partnership with Chemours exemplifies PCC Group’s commitment to grow in chemicals by building upon long-term relationships,” said Peter Wenzel, CEO, PCC SE. “We are dedicated to using our decades-long experience to safely and responsibly extend our chemical business at this facility. We look forward to a successful collaboration with such a major, globally renowned player as Chemours, setting a benchmark in the industry while evaluating further opportunities in the region.”

Source : Chemours